{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:25:21Z","timestamp":1777559121882,"version":"3.51.4"},"reference-count":15,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2007,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            A negative extended-spectrum \u03b2-lactamase (ESBL) confirmation test result obtained after a positive ESBL screening test result using Clinical and Laboratory Standards Institute methods has been a common occurrence among isolates of\n            <jats:italic>Escherichia coli<\/jats:italic>\n            and\n            <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n            in the SENTRY Antimicrobial Surveillance Program in the Asia-Pacific region. Among isolates collected between 1998 and 2004 this screen-positive, nonconfirmed profile (failed to show clavulanate synergy) was observed in 8.9% of 4,515\n            <jats:italic>E. coli<\/jats:italic>\n            isolates and 20.3% of 2,303\n            <jats:italic>K. pneumoniae<\/jats:italic>\n            isolates. We then selected 52\n            <jats:italic>E. coli<\/jats:italic>\n            isolates and 68\n            <jats:italic>K. pneumoniae<\/jats:italic>\n            isolates with a negative ESBL confirmation test, as well as comparable number of isolates with confirmed ESBL-positive tests, and examined them for the presence of TEM, SHV, plasmid-borne\n            <jats:italic>ampC<\/jats:italic>\n            , and CTX-M genes. We found that 62% of nonconfirming\n            <jats:italic>E. coli<\/jats:italic>\n            isolates and 75% of nonconfirming\n            <jats:italic>K. pneumoniae<\/jats:italic>\n            harbored a plasmid-borne AmpC enzyme of the CIT or DHA type. The majority of nonconfirming\n            <jats:italic>E. coli<\/jats:italic>\n            and\n            <jats:italic>K. pneumoniae<\/jats:italic>\n            from the Asia-Pacific region harbor important \u03b2-lactamases, and a positive screening test alone should be sufficient grounds to report resistance to extended-spectrum cephalosporins in this region.\n          <\/jats:p>","DOI":"10.1128\/jcm.02470-06","type":"journal-article","created":{"date-parts":[[2007,3,8]],"date-time":"2007-03-08T04:33:42Z","timestamp":1173328422000},"page":"1478-1482","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":31,"title":["Prevalence and Significance of a Negative Extended-Spectrum \u03b2-Lactamase (ESBL) Confirmation Test Result after a Positive ESBL Screening Test Result for Isolates of\n            <i>Escherichia coli<\/i>\n            and\n            <i>Klebsiella pneumoniae<\/i>\n            : Results from the SENTRY Asia-Pacific Surveillance Program"],"prefix":"10.1128","volume":"45","author":[{"given":"Jan M.","family":"Bell","sequence":"first","affiliation":[{"name":"Women's and Children's Hospital, Adelaide, South Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Chitsaz","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, South Australia, Australia"},{"name":"School of Medicine, Shahed University, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Turnidge","sequence":"additional","affiliation":[{"name":"Women's and Children's Hospital, Adelaide, South Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Barton","sequence":"additional","affiliation":[{"name":"Women's and Children's Hospital, Adelaide, South Australia, Australia"},{"name":"School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, South Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke J.","family":"Walters","sequence":"additional","affiliation":[{"name":"Women's and Children's Hospital, Adelaide, South Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald N.","family":"Jones","sequence":"additional","affiliation":[{"name":"JMI Laboratories, North Liberty, Iowa"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.12.3989-3993.2003"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(01)00353-4"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.14.4.933-951.2001"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/43.4.447"},{"key":"e_1_3_1_6_2","unstructured":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard 2006"},{"key":"e_1_3_1_7_2","unstructured":"Performance standards for antimicrobial susceptibility testing; 16th informational supplement M100-S16 2006"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2004.08.001"},{"key":"e_1_3_1_9_2","unstructured":"Antimicrobial wild-type MIC distributions of microorganisms 2006"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/44.3.377"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2005.04.004"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.5.1520-1525.2004"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.6.2153-2162.2002"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.1.1-11.2002"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.12.5715-5721.2004"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.3.647"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.02470-06","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.02470-06","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T05:47:49Z","timestamp":1646459269000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.02470-06"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["10.1128\/JCM.02470-06"],"URL":"https:\/\/doi.org\/10.1128\/jcm.02470-06","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5]]},"assertion":[{"value":"2006-12-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-02-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-05-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}